PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
£20.00
Buy Triptorelin Acetate Peptide in UAE – In Stock & Ready to Ship
Triptorelin Acetate is a widely researched peptide known for its role in gonadotropin releasing hormone and endocrine regulation studies. Each batch is independently verified at ≥99% purity and comes with a full Certificate of Analysis (COA) and HPLC testing documentation — giving UAE research teams the confidence they need when sourcing peptides for serious work.
For research use only. Not intended for human or veterinary use.
Triptorelin Acetate is the acetate salt form of Triptorelin — one of the most widely referenced synthetic GnRH agonist peptides in hypothalamic-pituitary-gonadal axis research — offering enhanced aqueous solubility, improved reconstitution characteristics, and superior stability in lyophilised form compared to the free base, making it the preferred salt form for controlled laboratory research protocols requiring precise, reproducible GnRH receptor pharmacology, HPG axis suppression studies, and gonadotropin regulation research in the UAE and across the GCC. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade Triptorelin Acetate with fast international dispatch and full batch documentation included.
✅ ≥99% Purity — HPLC & Mass Spectrometry Verified
✅ Batch-Specific Certificate of Analysis (CoA)
✅ Sterile Lyophilised Powder | GMP Manufactured
✅ Fast International Dispatch to UAE & GCC
Triptorelin Acetate is the acetate counter-ion salt form of Triptorelin — a synthetic decapeptide GnRH agonist analogue of native Gonadotropin-Releasing Hormone. The acetate salt designation refers to the pairing of the Triptorelin peptide cation with an acetate anion to form a stable salt complex, a standard pharmaceutical and research chemistry approach used to optimise the physical and chemical properties of peptide compounds for laboratory use.
The core pharmacological identity of Triptorelin Acetate is identical to Triptorelin base — it carries the same ten amino acid sequence with the same amino acid substitutions that enhance GnRH receptor binding affinity and extend half-life beyond native GnRH’s 2–4 minutes. The acetate salt form does not alter the peptide’s receptor binding characteristics or downstream HPG axis pharmacology — it optimises the compound’s physical properties for research practicality.
The primary advantages of the acetate salt form in research settings are improved aqueous solubility — enabling cleaner, more consistent reconstitution in aqueous laboratory buffers — and enhanced lyophilised powder stability, which is particularly relevant for research institutions in the UAE and GCC where storage and handling conditions may vary. The acetate form is the most commonly supplied and referenced salt form of Triptorelin in published research literature, making it the standard form for researchers seeking alignment with established protocols.
As with Triptorelin base, Triptorelin Acetate acts as a potent GnRH receptor agonist — initially stimulating LH and FSH release from pituitary gonadotroph cells with acute exposure, before producing profound and reversible HPG axis suppression through receptor downregulation and pituitary desensitisation with sustained continuous administration. This dual pharmacological profile makes it one of the most mechanistically versatile GnRH analogue research tools available.
In laboratory settings, Triptorelin Acetate research applications are identical to Triptorelin base, with the acetate form offering improved handling characteristics for protocols requiring precise aqueous reconstitution. Research applications include:
The acetate salt form’s superior aqueous solubility makes it particularly well-suited for in vitro cell-based assays and receptor binding studies where consistent peptide concentration in aqueous media is critical to experimental reproducibility. All applications are for research use only.
Triptorelin Acetate shares the same extensive and well-characterised research literature base as Triptorelin, with the acetate form being the predominant salt form referenced across published GnRH agonist research:
GnRH receptor pharmacology research has comprehensively characterised Triptorelin’s binding profile in its acetate salt form — with studies documenting significantly higher receptor binding affinity compared to native GnRH, confirming that the amino acid substitutions in Triptorelin’s sequence enhance receptor interaction while the acetate counter-ion has no effect on receptor binding characteristics. These studies have established Triptorelin Acetate as the reference form for GnRH agonist receptor pharmacology research across the analogue class.
HPG axis suppression research conducted with Triptorelin Acetate has extensively characterised the pituitary desensitisation mechanism — documenting the full sequence from initial acute gonadotropin stimulation through receptor internalisation, gonadotroph downregulation, and sustained LH/FSH suppression. The acetate form’s consistent aqueous reconstitution has made it the preferred form for studies requiring precise, reproducible dose administration in pre-clinical suppression protocols.
Testosterone suppression research has used Triptorelin Acetate in pre-clinical models to examine LH suppression-driven Leydig cell quiescence and downstream testosterone production inhibition — with studies characterising the timeline, depth, and reversibility of androgen suppression following sustained GnRH receptor downregulation. These findings have positioned Triptorelin Acetate as a key reference compound in androgen deprivation biology research.
Hormone-sensitive cancer biology research has examined Triptorelin Acetate’s effects in pre-clinical models of hormone-dependent tumour biology — with studies exploring how HPG axis suppression influences androgen and oestrogen-dependent cell line biology, contributing to the broader research into sex hormone manipulation in hormone-responsive tissue models. Comparative salt form research has examined how Triptorelin Acetate’s physical properties — solubility, reconstitution behaviour, and lyophilised stability — influence experimental outcomes in sensitive assay formats, providing practical research data on how peptide salt form selection affects laboratory protocol performance.
| Compound | Form | Aqueous Solubility | Lyophilised Stability | Pharmacology | Research Profile |
|---|---|---|---|---|---|
| Triptorelin Acetate | Acetate salt | Superior | Excellent | Identical to base | Most referenced form |
| Triptorelin (free base) | Free base peptide | Good | Good | Identical to acetate | Well-documented |
| Leuprolide Acetate | GnRH agonist acetate | Superior | Excellent | GnRH agonist | Extensively studied |
| Buserelin Acetate | GnRH agonist acetate | Superior | Excellent | GnRH agonist | Well-documented |
| Gonadorelin Acetate | Native GnRH acetate | Superior | Excellent | Pulsatile GnRH agonist | Well-documented |
| Cetrorelix Acetate | GnRH antagonist acetate | Superior | Excellent | Immediate GnRH antagonism | Well-documented |
| Parameter | Triptorelin Acetate | Triptorelin Base |
|---|---|---|
| Counter-ion | Acetate | None |
| Aqueous solubility | Superior — faster, cleaner dissolution | Good |
| Reconstitution consistency | Excellent — preferred for precise dosing | Good |
| Lyophilised stability | Enhanced | Standard |
| GnRH receptor binding | Identical | Identical |
| HPG axis pharmacology | Identical | Identical |
| Published literature alignment | Primary referenced form | Secondary form |
| Preferred for | In vitro assays, precise dose-response studies | General research protocols |
| Parameter | Detail |
|---|---|
| Type | Synthetic Decapeptide GnRH Agonist — Acetate Salt |
| Also Known As | Triptorelin Acetate, LHRH Agonist Acetate |
| Salt Form | Acetate counter-ion |
| Primary Target | GnRH Receptor (GnRHR) on pituitary gonadotrophs |
| Chain Length | 10 Amino Acids |
| Half-Life | ~3 hours |
| Purity | ≥99% |
| Verification | HPLC & Mass Spectrometry |
| Form | Lyophilised Powder |
| Solubility | Sterile water or bacteriostatic water — superior dissolution |
| Storage | -20°C, protected from light and moisture |
| Intended Use | Research use only |
Every order dispatched to the UAE and GCC includes:
Yes. We supply research-grade Triptorelin Acetate with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged to maintain peptide integrity throughout transit. This compound is supplied strictly for laboratory research use only.
The pharmacological activity of Triptorelin Acetate and Triptorelin base is identical — both contain the same ten amino acid GnRH agonist sequence with the same receptor binding characteristics and HPG axis pharmacology. The difference is purely physical and chemical: the acetate salt form pairs the Triptorelin peptide with an acetate counter-ion, improving aqueous solubility, reconstitution consistency, and lyophilised powder stability. For research protocols requiring precise aqueous concentration preparation — particularly in vitro cell-based assays and receptor binding studies — the acetate form’s superior solubility characteristics make it the preferred choice and the most commonly referenced form in published research literature.
In vitro research protocols — including cell-based assays, receptor binding studies, and dose-response experiments — require consistent, reproducible peptide concentrations in aqueous media. The acetate salt form’s superior aqueous solubility ensures faster, cleaner dissolution and more predictable concentration achievement compared to free base peptides, reducing the risk of concentration variability that could confound experimental results. For sensitive assay formats where precise peptide concentration is critical to data quality, the acetate form’s reconstitution advantages make it the standard choice in published GnRH agonist research protocols.
No. The acetate counter-ion dissociates from the Triptorelin peptide in aqueous solution and has no interaction with GnRH receptors. Receptor binding is determined entirely by the Triptorelin peptide sequence and its structural complementarity with the GnRH receptor binding pocket — which is identical between Triptorelin Acetate and Triptorelin base. Studies comparing GnRH receptor binding affinity between salt forms have confirmed equivalent receptor interaction, validating the use of either form for receptor pharmacology research with equivalent biological outcomes.
Triptorelin Acetate is the predominant form referenced in published HPG axis research — with studies characterising the full spectrum of GnRH agonist biology from acute gonadotropin stimulation through pituitary desensitisation and sustained LH/FSH suppression. Pre-clinical studies have documented testosterone and oestrogen suppression timelines, gonadotroph receptor downregulation mechanisms, and HPG axis recovery dynamics following withdrawal — establishing a comprehensive research profile that spans the complete pharmacological lifecycle of GnRH agonist administration from initial receptor engagement to full HPG axis reactivation.
Allow the vial to reach room temperature before opening. Add sterile or bacteriostatic water slowly down the vial wall and swirl gently without shaking. The acetate salt form dissolves rapidly and cleanly in aqueous media — prepare at your protocol’s required concentration. Aliquot and store at -80°C to minimise freeze-thaw degradation and maintain peptide integrity between experimental sessions. The acetate form’s superior solubility makes it particularly suitable for preparing stock solutions at higher concentrations for subsequent dilution in sensitive assay formats.
Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain peptide stability and integrity throughout transit.
Triptorelin Acetate is supplied exclusively for legitimate scientific research conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic or veterinary application. It must be handled solely by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. By purchasing, you confirm this compound will be used exclusively for approved in vitro or pre-clinical research purposes.
Receive News
